Publisher’s note: This Roundup aims to highlight some of the most notable financing cycles of the month and is not intended to be complete.
Health technology companies made several major financing announcements in September. Here is a list of some of the largest financing rounds.
Screw up the health rakes in funding of $ 550 million
Strive Health Denver, Colorado, Works with payers, health systems, primary care groups and nephrologists. It offers home and virtual support for chronic kidney diseases, terminal kidney disease, dialysis and renal transplantation. The company uses technology and AI to identify patients in disease phase and what are the best interventions. In addition, he connects patients to a care team that includes a practitioner nurse, an authorized nurse, a case manager and a care coordinator.
Its funding included $ 300 million in equity funding and $ 250 million in loan funding. The joint -stock financing was led by New Enterprise Associates (NEA) and included the participation of CVS Health Ventures, Capital, Echo Health Ventures, Town Hall Ventures, Redpoint and the affiliates of Blackrock. Hercules Capital led the financing of the debt. Funding will help strive to invest in AI and expand its care provision under additional conditions, such as congestive heart failure.
Capital RX obtains $ 400 million in funding
Capital RX is a transparent pharmacy service manager who now refers as a Judi Health that she develops beyond pharmacy services. It also offers a social management solution for employers, ATT and health plans. It provides care for navigation on care for benefits in pharmacies, medical, vision and dental. In addition, it provides a software solution as a service to help health plans manage their workflows.
The investment of $ 400 million includes $ 252 million in FI Funding in Wellington Management and General Catalyst, with the participation of Generation Investment Management, Growth Equity at Goldman Sachs Alternatives, 9yards Capital, B Capital, Edison Partners, Prime Health Investments and Transformation Capital. It also includes additional investments in the securities of the company, which means that investors buy stocks from existing stakeholders.
Thym Care increases $ 97 million in series financing
The Nashville thyme, based in Tennessee, is associated with health plans, employers and risk suppliers to help patients fight cancer. It provides healthcare navigation services, technology and data and therapeutic interventions. The company helps patients understand their diagnosis, find a cancer doctor and receive clinical care between appointments. Patients also have access to a team of providers, nurses and resources specialists.
The Tour of the Dollars Series D included the participation of CVS Health Ventures, Foresite Capital, A16Z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, Frist Cresse Ventures, Morgan Health, Humana, Texas Oncology and Memorial Hermann Health System. Thym Care raised 275 million dollars in total. Funding will help extend its paying contracts, to evolve to more customers, to develop its partnerships in oncology and to invest in AI.
Assorm Health increases $ 76 million in series B financing
The health of the assorted based in San Francisco uses AI to improve the way in which supplier practices and hospitals engage with patients. Its AI agents are part of electronic health files and practice management systems to manage routine telephony requests, help meet appointments and guide patients to appropriate care. The platform supports a range of specialties, including orthopedics, cardiology and pediatrics.
His series B was led by Lightspeed Venture Partners and included the participation of Felicis, First Round Capital, Chemistry, A *, Liquid2 and Quiet Capital. The company has raised $ 102 million to date. Funding will be used to develop the ASSOR Santé team and advance the development of its platform.
Imagine Pediatrics obtains 67 million dollars in series B financing
Imagine Pediatrics, based in Nashville, provides virtual and home care for children with specific health needs. His team offers medical, behavioral and social support. The company now serves around 40,000 children across the country.
Its funding of $ 67 million included the participation of OAK HC / FT, Optum Ventures, Rubicon Founders and Autism Impact Fund. It will “accelerate national expansion, will improve the technological platform owner of the company and fuel clinical innovation designed to fill persistent care gaps and extend access to specialized pediatric care for children with special health care needs,” said the ad.
Photo: Sylverarts, Getty Images
